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Abstract
Background: Hospital deaths following several hospital admissions or long hospital stays may be indicative of a
low quality of dying. Although place of death has been extensively investigated at population level, hospital use in
the last months of life and its determinants have been studied less often, especially in Europe and with a general
end-of-life patient population. In this study we aim to describe hospital use in the last three months of life in
Belgium and identify associated patient, disease and healthcare factors.
Methods: We conducted a retrospective registration study (13 weeks in 2004) with the Belgian Sentinel
Network of General Practitioners, an epidemiological surveillance system representative of all GPs in Belgium,
covering 1.75% of the total Belgian patient population. All registered non-sudden or expected deaths of patients
(aged one year or older) at the GPs' practices were included. Bivariate and regression analyses were performed.
Results: The response rate was 87%. The GPs registered 319 deaths that met inclusion criteria. Sixty percent
had been hospitalised at least once in the last three months of life, for a median of 19 days. The percentage of
patients hospitalised increased exponentially in the last weeks before death; one fifth was admitted in the final
week of life. Seventy-two percent of patients hospitalised at least once in the final three months died in hospital.
A palliative treatment goal, death from cardiovascular diseases, the expression of a wish to die in an elderly home
and palliative care delivery by the GP were associated with lower hospitalisation odds.
Conclusion: Hospital care plays a large role in the end of patients' lives in Belgium, especially in the final weeks
of life. The result is a high rate of hospital deaths, showing the institutionalised nature of dying. Patients' clinical
conditions, the expression of preferences and also healthcare characteristics such as being treated as a palliative
care patient, seem to be associated with hospital transfers. It is recommended that hospitalisation decisions are
only made after careful consideration. Short admissions in the final days of life should be prevented in order to
make dying at home more feasible.
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Long or repeated hospital admissions at the end of life
and death in a hospital setting could be an indicator of a
low quality of dying [1-3]. Although some end-of-life hos-
pitalisations are necessary and could benefit the patients,
patients express an overall preference to die at home in the
presence of their loved ones [4,5]. Additionally, aggressive
life-prolonging and possibly futile interventions, often in
opposition to the palliative care needs and preferences of
patients at the end of their lives, are more likely to be car-
ried out in hospitals, and patients in institutions have
higher rates of unmet physical and psychosocial needs
than patients dying at home [6-8]. Reduction of the time
spent in the hospital and of the number of hospital
admissions is therefore an important issue in palliative
care [9,10].
In several countries, including Belgium, death has become
institutionalised, with most people dying in hospital [11-
13]. Although place of death and its determinants has
been extensively investigated [11,12,14-16], hospital use
and transitions between care settings in the last months of
life and its determinants have been studied less often. This
is especially the case in Europe and with a general end-of-
life patient population. Studies that investigate hospital
use at the end of life are often limited to specific diagnoses
(e.g. cancer) [9,17], age groups (e.g. the elderly) [18-21],
or settings (e.g. hospital, nursing homes or specialist pal-
liative care services) [22,23] and they focus on specific
determinants of hospital use (e.g. hospice involvement)
[10,22].
Analyses of the timing and nature of hospital use at the
end of life can provide important information on the
opportunities and challenges faced in the planning and
implementation of healthcare services for dying patients.
This could enable more people to be cared for and to die
where they want to.
The purpose of this study is to describe hospital use in the
last three months of patients' life, regardless of the place
or cause of death, and to identify patient, disease and
healthcare factors associated with hospital use. In this
study, a general end-of-life patient population was identi-
fied over a three-month registration period by a Sentinel
Network of General Practitioners in Belgium [24]. This is
the first study reporting on hospital use at the end of life
in Belgium. Our specific research questions were:
How many patients are hospitalised during the last three
months of life, and how often does this occur?
How many days do patients spend in the hospital and in
what period during the last three months of life?
What patient, disease and healthcare factors are associated
with hospital use during the last three months of life?
Methods
Study design
The data for this study was collected by the Belgian Senti-
nel Network of General Practitioners (GPs), a weekly reg-
istering network operational since 1979 under the
authority of the Scientific Institute of Public Health in Bel-
gium. The network has proved to be a reliable surveillance
system for health-related epidemiological data [24]. Its
participants are representative of the profile of family phy-
sicians in Belgium, i.e. in terms of age, sex and homogene-
ous geographical distribution [25]. The network covers
1.75% of the total Belgian patient population.
We conducted a retrospective registration study with this
network, including all deaths of patients aged one or
older, occurring between April and June 2004 (13 consec-
utive weeks) as well as the last death before this period. To
shorten the time between death and registration – hence
preventing recall bias as much as possible – the physicians
were instructed to register all deaths, immediately after
being informed about the patient's death, on a continu-
ous basis during the months of inclusion. To optimise
accuracy of the data registered, they were also instructed to
use patient records and information coming from hospi-
tal physicians as much as possible.
In order to identify a general end-of-life population
[26,27], additional inclusion criteria for this study were
patients who were part of the GP's (group) practice and
whose death was labelled non-sudden or expected.
Several control measures (such as data-entry with consist-
ency, range and skip checks, possibility of contacting GPs
by phone, double data-entry) were used to ensure data
quality and to prevent missing data.
The anonymity of the patient and the physician was pre-
served. The protocol of the study was approved by the Eth-
ical Review Board of the University Hospital of the Vrije
Universiteit Brussel.
Questionnaire
The network GPs filled in a structured, standardized ques-
tionnaire for each death case. The first part surveyed the
patient's date of birth and death, sex, overall socio-eco-
nomic status (estimated by GP), the postal code of their
habitual residence and the cause of death (encoded into
ICD-10 codes). For all non-sudden deaths of patients that
were part of the GP's (group) practice, a second part was
filled in measuring characteristics of the last three months
of life:Page 2 of 9
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of each hospital stay
- patient's wish concerning the place of death if expressed
to the GP: "Were you informed (verbally or in writing) of
the patient's preference with regard to their place of
death?" And if so, "where did this patient wish to die?"
- continuity and GP support variables:
 GP's palliative care delivery: "Did you provide palliative
care to this patient?" Yes (until death or not until death)
or No.
 Number of GP contacts with the patient or relatives, con-
cerning the patient (home visits or consultations, exclud-
ing telephone contact)
- social support variables: living situation, informal care
delivery ("how often were partner, children, or other peo-
ple actively involved in the care provided to this patient?")
- main focus of treatment (palliative versus curative/life-
prolonging)
- involvement of specialist palliative home care and/or
elderly home care teams.
The number of GP contacts, informal care delivery and the
focus of treatment were measured in three separate time
frames (the final week, second to fourth week and second
to third month before death).
Data analysis
We calculated the proportion of patients hospitalised for
at least one day during the last three months of life and
the number of times they were admitted to the hospital in
this period. The total number of days spent in hospital
was calculated by summing the lengths of stay of all
admissions. A stay in a specialist palliative care unit was
not considered a hospital stay because of the large differ-
ences in cultures (care versus cure) between the two set-
tings. In a limited number of cases, hospitalisation
decisions made at home might be deflected to a stay in a
palliative care unit, but GPs would probably be informed
of this by the specialist caregivers in these units.
We calculated mean (standard deviation) and median
(interquartile range) length of hospital stay in days for all
patients admitted to a hospital for at least one day. To
explore time trends in hospital use, we described when
patients were admitted to the hospital and how many
died there. We also calculated the hospitalisation rate
defined as the proportion of patients who were in a hos-
pital on day X before death.
We structured the possible determinants of hospital use at
the end of life (patient, disease and healthcare characteris-
tics) based on previously published models on the deter-
minants of healthcare use and place of death [5,28,29].
We used Pearson Chi2 tests to explore bivariate associa-
tions between these characteristics and the fact of being
hospitalised for at least one day in the final three months
of life or not being hospitalised, and logistic regression to
calculate adjusted odd-ratios.
To explore factors associated with the length of hospital
stays, the nonparametric analysis of variance (Kruskal
Wallis test) was used in the bivariate analyses and a linear
regression model in the multivariate analyses (the
dependent variable in the model, number of hospital
days, was logarithmically transformed to achieve a near-
normal distribution). The independent variables meas-
ured in three time frames were concatenated to an overall
score during the three final months of life. For example,
treatment goal – measured in the last week, second to
fourth week and second to third month before death –
was concatenated to "curative/life-prolonging in last three
months" or "palliative in last three months", or "from cur-
ative/life-prolonging to palliative in the last month or
week of life". We used the postal codes of patients' resi-
dence to calculate the local degree of urbanization and
ratio of hospital beds per 1000 inhabitants, using data
from various ecological healthcare statistics available in
Belgium. Analyses were performed using SPSS13.0.
Results
Of the panel of 202 GP practices participating in the Sen-
tinel Network in 2004, 176 (= 87%) reported one or more
deaths. In total 502 deaths were reported, of which 332
were part of the GPs' (group) practices and died non-sud-
denly or expectedly. Thirteen cases were subtracted due to
incomplete care trajectories. Hence the results of this
study are based on 319 non-sudden deaths.
Age, sex, cause and place of death of these non-sudden
deaths in the Dutch-speaking part of Belgium (n = 191)
were compared with the non-sudden deaths identified in
another study (2001) on end-of-life decisions representa-
tive for all deaths in this part of the country (n = 2128)
[30]. The percentages of these characteristics in both
groups showed no significant differences (using Multino-
mial 95% Confidence Intervals, exact method; data not
shown). No comparison data was available for the
French-speaking part of the country (i.e. 40% of the Bel-
gian population).
Number of hospitalisations, length and timing of hospital 
stay
Table 1 shows that 60% of the patients stayed in a hospital
for at least one day in the last three months of life. OnePage 3 of 9
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three times in this period. The median length of hospital
stay was 19 days. Figure 1 shows the variation in length of
hospital stay in detail. One fifth of the patients had short
hospital stays of one week or less. A majority of patients
(57%) was hospitalised for three weeks or less.
Eighteen percent of hospital admissions took place in the
week before death, 35% in the preceding three weeks and
47% in the preceding months (Table 1). All but one of the
patients who were admitted in the final week of life died
there. Overall, 72% of the patients hospitalised for at least
one day in their last three months died in hospital.
Figure 2 shows the proportion of patients who were in a
hospital on day X within the last three months before
death. The percentage of patients hospitalised increased
gradually in months three and two before death and expo-
nentially as they got closer to death. Three months before
death, 8% were hospitalised, increasing to 18% one
month before death and 43% on the last day of life (=
place of death). Patients who only stayed in hospital for
short lengths of time (e.g. one to seven days) were mainly
hospitalised in the final week (data not shown).
Patient, disease and healthcare factors associated with 
hospital use
Table 2 lists the proportion of patients hospitalised or not
in the last three months of life for subgroups of patients
defined by patient, disease and healthcare characteristics.
Hospital admission occurred most often among patients
older than 65 and younger than 85 years old. Males were
more often admitted than females, and patients whose
wish for place of death was not known by the GP and
patients who expressed a wish to die in a hospital or pal-
liative care unit, were more often hospitalised.
With respect to healthcare characteristics, hospitalisation
rates were higher where GP support was lower, i.e. if the
GP reported not having delivered palliative care or if s/he
had had a low number of contacts with the patient or rel-
atives. Social support was also related to hospitalisation,
with patients living at home alone, with children under 18
years old or alone with a partner, more often hospitalised,
than patients living at home with a partner and other
adults, or in an institution. Involvement of specialist pal-
liative care in the elderly homes and a treatment with a
palliative (rather than curative or life-prolonging) focus,
was associated with a lower percentage of hospitalised
patients.
While many characteristics were related to hospital admis-
sion, few were associated with the length of hospital stay
(data not shown). In general, the differences in averaged
or median length of stay for the subgroups of patients
were small. Lower averages of length of hospital stay were
found for patients receiving palliative care from the GP (p
= .022) and for patients whose treatment focus was palli-
ative (p = .013).
Multivariate logistic regression analyses (Table 3) shows
that the odds of being hospitalized were four times lower
if a wish to die in an elderly home was known to the GP.
Patients who had expressed a wish to die at home had the
same chance of being hospitalised as patients whose
wishes were not known. If the GP provided palliative care,
his/her patients had a four times lower likelihood of being
hospitalised. Cause of death was not retained in the bivar-
iate analyses, but, if adjusted for the other characteristics,
patients with malignancies were more often hospitalised
than those with cardiovascular diseases (three to four
times more often) and equally often as those with diseases
of the nervous system. Finally, a curative goal of treatment
during the entire last three months of life increased the
Table 1: Hospital use in the last three months of life (N = 319) *
N (%)
Not hospitalised 127 (39.8)
Hospitalised at least one day 192 (60.2)
Hospitalised once 155 (80.7)
Hospitalised twice 36 (18.8)
Hospitalised three times 1 (0.5)
If hospitalised in the last three months of life (N = 192):
Mean [sd] length of hospital stay in days 26.2 [23.9]
Median [interquartile range] length of hospital stay in days 19 [9 – 35]
Last hospital admission [number (%) of hospital 
deaths]
in last week before death: 34 (17.7) [33 (97.1)]
in second to fourth week before death: 67 (34.9) [52 (77.6)]
in second to third month before death: 91 (47.4) [53 (58.2)]
Death in hospital [138 (71.9)]
* Within this population, we observed no differences between the reported deaths occurring between April and June of 2004 and the last death 
before this period regarding number of hospitalisations, length nor timing of hospital stay at the end of life.Page 4 of 9
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treatment goal was changed from cure or life-prolonging
to palliative care in the final month or week of life had a
chance of hospitalisation that was twice as high as for
patients whose treatment had been focussed on palliative
care during the entire last three months of life. If patients
whose treatment goal changed were hospitalised, this usu-
ally occurred before their final month of life (data not
shown).
No multivariate linear regression model could be con-
structed for length of hospital stay because no entered var-
iables were retained.
Discussion
Hospital care plays a large role in patient care at the end
of life. In Belgium, two out of three dying patients are hos-
pitalised at least once during the final three months. The
average patient spends approximately three weeks in hos-
pital, but a large inter-individual variation in length of
stay could be observed. The proportion of hospitalised
patients increased exponentially in the last month before
death – one fifth were admitted in the last week – with a
high rate of hospital deaths as a result. A palliative treat-
ment goal, death from cardiovascular diseases, expression
of a wish to die in an elderly home and palliative care
delivery by the GP were associated with a lower likelihood
of being hospitalised in the last three months of life.
In this study, we were able to measure hospitalisation and
associated patient, disease and healthcare characteristics
in the final three months of life in a general sample of
non-sudden deaths, irrespective of diagnoses or care set-
ting. This was possible via the Belgian Sentinel Network of
GPs because the network is representative of the GP pro-
file in Belgium [25] and almost all of the population
(95%), including elderly home residents, have a regular
GP, who is easily accessible and consulted on a regular
basis [31]. The network has proved to be a reliable surveil-
lance system for health-related epidemiological data cov-
ering 1.75% of the total Belgian patient population
[24,32]. The non-sudden deaths identified in this study –
in the Dutch-speaking part of the country, i.e. 60% of the
population – were judged representative for all non-sud-
den deaths in this part of the country [30]. We could
gather high quality data because co-operation of the GPs
in the network is optimal, because they are familiar with
scientific registration and because quality control meas-
ures were used [24,25].
There were also some limitations, however. Firstly,
because the observational unit of this study was the GP,
we did not evaluate subjective states such as patients'
quality of life or symptom burden which might have fur-
ther explained hospital transfers. Secondly, the retrospec-
tive design of the study could have induced recall bias
among the GPs and therefore could have influenced the
results. Retrospective reconstructions of the care provided
might also deviate from the actual care given. Finally, rela-
tionships between cause and effect could not be estab-
lished in our study: we could only explore associations
between characteristics and hospitalisation.
The results of this study show the institutionalised nature
of the final phase of life in Belgium. The high frequency of
hospital transfers and high hospital use emphasises the
fact that acute care hospitals play a large part in meeting
the needs of dying patients, with an exponential rise in the
last month of life leading to a high proportion of hospital
Hospitalisation rate in the last three months of life (n = 319)Figure 2
Hospitalisation rate in the last three months of life (n = 319).
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Table 2: Patient, disease and healthcare factors associated with hospital use in the last three months of life (n = 319)
Not hospitalised
(n = 127)
Hospitalised at 
least one day
(n = 192)
p-value*
PATIENT AND DISEASE FACTORS Total N † % %
Age at death 1–64 y 42 42.9 57.1 .008
65–74 y 74 29.7 70.3
75–84 y 109 34.9 65.1
+85 y 91 53.8 46.2
Sex male 164 31.7 68.3 .003
female 155 48.4 51.6
Socio-economic status low 77 41.6 58.4 .90
medium 205 39.0 61.0
high 31 41.9 58.1
Degree of urbanization § core of large city 108 42.6 57.4 .33
high 71 31.0 69.0
average 76 40.8 59.2
low or rural 62 45.2 54.8
Place of death wish expressed to GP home or living with family 96 54.2 45.8 <.001
home for the elderly 37 73.0 27.0
elsewhere (hospital, palliative care unit) 17 23.5 76.5
not expressed 157 23.6 76.4
Cause of death (ICD-10) malignancies 124 35.5 64.5 .40
cardiovascular diseases 83 44.6 55.4
diseases of the nervous system 13 53.8 46.2
other 97 38.1 61.9
HEALTHCARE FACTORS
Hospital beds in healthcare area
(rate/1000 inhab) ‡
<5.658 185 43.2 56.8 .16
>=5.658 133 35.3 64.7
CONTINUITY AND GP SUPPORT
Palliative care delivered by GP in last three months yes 146 61.6 38.4 <.001
no 171 20.5 79.5
Total number of GP contacts in last three months 
(consultations, home visits)
low [0–6] 113 26.5 73.5 .001
medium ]6 – 11] 105 44.8 55.2
high ]11 – 88] 101 49.5 50.5
SOCIAL SUPPORT
Living situation § at home, with partner and other adults: 51 54.9 45.1 .003
at home, with partner but no other adults: 115 30.4 69.6
at home, single or with children aged <18 y: 51 31.4 68.6
living elsewhere without family: || 95 49.5 50.5
Informal care (partner, child, acquaintance,...) in last 
three months
none or very little 111 36.0 64.0 .46
yes, sometimes 133 43.6 56.4
yes, often 49 42.9 57.1
INVOLVEMENT OF SPECIALIST PALLIATIVE CARE
Specialist palliative home care team yes 37 54.1 45.9 .11
no 260 38.8 61.2
Specialist palliative elderly home care team yes 21 76.2 23.8 .001
no 276 38.0 62.0
FOCUS OF TREATMENT
Treatment goal in last three months curative/life-prolonging: 79 12.7 87.3 <.001
palliative: 76 64.5 35.5
from curative/life-prolonging to palliative: 130 42.3 57.7
from palliative to curative/life-prolonging: ¶ 2 - 100.0
* p-value for all variables (Pearson χ2-test); significant values are bold
† missing values (not responded or unknown) not included in bivariate analyses: for age n = 3; for socio-economic status n = 6; for degree of urbanization n = 2; for patient's 
wish for place of death n = 12; for cause of death n = 2; for hospital beds rate n = 1; for palliative care delivered by GP n = 2; for living situation n = 7; for informal care n = 
26; for specialist palliative caren = 22; for treatment goal n = 32
‡ measured on level of care districts or provinces, dichotomised at their median values; §on the basis of patient residence
|| 87.4% of this group are elderly home residents
¶ not included in analyses
Abbreviations: GP = General Practitioners
BMC Health Services Research 2007, 7:69 http://www.biomedcentral.com/1472-6963/7/69deaths. The organization of healthcare in Belgium seems
clearly oriented towards specialist care provision with a
low threshold for specialist hospital care. Research in spe-
cific patient populations in Canada [17], the US [22] and
Europe [9,23] is consistent with this study, i.e. increasing
hospitalisation rates during the last month of life, but
detailed comparisons are difficult mainly because other
inclusion criteria were used such as cancer patients,
patients in hospitals or specialist palliative care.
An interesting finding is that if a patient is hospitalised at
some time during the final 3 months of life, the chance of
dying in a hospital is very high: 72% of patients hospital-
ised at least once died in a hospital. Since few patients
have multiple transfers to a hospital and many hospitali-
sations occur in the final days or weeks before death, this
finding suggests that for many patients the decision to
hospitalise is tantamount to the decision to die in the hos-
pital.
Several patient, disease and healthcare characteristics are
closely related to hospital admissions. It is striking that
not only patients' clinical condition (e.g. cancer) is indic-
ative for whether or not they are hospitalised, but that a
treatment focused on palliative care instead of life-prolon-
gation or cure considerately lowers the chance of being
hospitalised. This is consistent with one of the goals of
palliative care, which is to reduce hospitalisation rates at
the end of life, and also with the cure-oriented culture
attributed to hospital settings [9]. Being a "palliative care
patient" seems to be an important consideration when
making transfer decisions. Unfortunately, palliative care is
often started too late [33] and the survival time of dying
patients is often overestimated [34], possibly leading to a
high number of hospitalisations at the end of life.
Patients who have expressed a wish for home death were
hospitalised as often as patients whose wish was not
known to the GP, but elderly home residents who
expressed a wish to die there were hospitalised less often.
A possible explanation is the presence of professional car-
egivers in elderly homes which makes it possible to carry
out their wishes, while patients at home often depend on
informal caregivers who possibly cannot provide the com-
plex care needed for extended periods of time at the end
of life [28,34]. The heavy burden on GPs who treat dying
patients at home might also explain why patients' wishes
for home death are carried out less often than those of eld-
erly home patients. In both settings, wishes might also
have been expressed after a first hospitalisation and con-
sequently prevented a second admission, which would
further strengthen the relationship between expression of
wishes and hospitalisation. However, this cannot be
determined from our data and should be studied in future
research.
The GP might also play an important role in the hospital-
isation decision. If the GP perceived that he or she deliv-
ered palliative care to the patient, the odds of being
hospitalised were smaller. In accordance with studies on
GPs' palliative care delivery, this could mean that a lack of
GP involvement in palliative care, often related to a lack
of confidence in their own palliative care skills [35], leads
to high hospitalisation rates. However, hospitalisation
itself might be the reason why GPs' involvement in palli-
ative care delivery was lower. Furthermore, the GP might
Table 3: Logistic regression analyses of factors associated with hospital use in the last three months of life (n = 319) *
Beta Standard Error Odds-ratios [95%CI] †
Hospitalised or not
Place of death wish expressed to GP not expressed: 1.00 [1.00-1.00]
home or living with family: -0.603 0.348 0.547 [0.277–1.083]
home for the elderly: -1.404 0.493 0.246 [0.093–0.645]
elsewhere (hospital, palliative care unit): 0.263 0.678 1.301 [0.345–4.908]
Palliative care delivered by GP no 1.00 [1.00-1.00]
yes -1.405 0.366 0.245 [0.120–0.503]
Cause of death (ICD-10) malignancies 1.00 [1.00-1.00]
cardiovascular diseases -1.305 0.390 0.271 [0.126–0.582]
diseases of the nervous system -0.284 0.902 0.753 [0.129–4.411]
other -1.053 0.374 0.349 [0.168–0.726]
Treatment goal in last three months before death ‡ palliative: 1.00 [1.00-1.00]
curative/life-prolonging: 1.686 0.517 5.398 [1.958–14.882]
from curative/life-prolonging to palliative: 0.830 0.353 2.293 [1.147–4.584]
* Multivariate logistic regression analyses for hospitalised (at least one day) (1) versus not hospitalised (0) patients; Missing values were included as 
a separate category if N>20; Variables entered in the regression were all variables significant in the bivariate analyses and cause of death, hospital 
beds in the healthcare area, degree of urbanization, and informal care provided [entered on the basis of results of other research e.g. (3)]. 
Interaction effects of the remaining variables were entered in the regression but not significant. No problems of multi-collinearity were observed.
† Odds-ratios with 95% Confidence Intervals are displayed; significant relationships are bold; Model summary results: Nagelkerke R Square = 0.368; 
Percentage correctly predicted = 76%;
‡ the subcategory "from palliative to curative/life-prolonging (n = 2) was not included in analyses
Abbreviations: GP = General Practitioners, ICD-10 = International Classification of Diseases version 10Page 7 of 9
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involvement based upon what actually happened at the
end of the patient's life. This relationship should be inves-
tigated in more detail in future research before definite
conclusions can be drawn.
The involvement of multidisciplinary palliative home or
elderly home teams supporting the GP seems to have no
association with hospital admission, which is inconsist-
ent with some results in other studies [10]. A possible
explanation is the late onset of these specialized health-
care services [33], often during the last week of life. An
effect on hospitalisation rates can only be measured after
their initialisation, while we focused on a three-month
period in this study. Furthermore, patients might have
been hospitalised before their involvement. Future
research should register the timing and intensity of their
involvement in patient care.
Finally, a key question is whether end-of-life hospitalisa-
tions are necessary and whether they benefit the patient.
Some hospitalisations are indeed necessary, especially if a
specific hospital treatment is needed e.g. in the case of a
60-year-old patient who was admitted for curative chem-
otherapy 3 months before death, when cure was still
believed possible. Also, the increase in complex medical
problems at the end of life makes them difficult to man-
age at home or in an elderly home. On the other hand, the
necessity of many hospitalisations at the very end, espe-
cially those short stays in the final weeks of life, as well as
admissions of this fragile population for long periods of
time, could be questioned. Most patients do not want to
die in a hospital [4]. Transferring them at the end of their
life might be extremely stressful, since their caregivers and
environment would change abruptly [36]. Hospital care is
often aggressive, which might oppose to the palliative care
needs of many dying patients, especially at the very end of
life [6-8]. Also, several problems with continuity of care
might arise from these transfers [36] such as information
concerning patient wishes to receive or not receive specific
treatments (e.g. do-not-resuscitate orders) might not be
transferred. Of course, acute situations cannot be fully
prevented. However, even then, adequate advance care
planning, taking into account patient preferences,
remains important.
Conclusion
In Belgium, dying is highly institutionalised. Hospital
transfers rise in the last weeks before death, leading to a
high rate of hospital deaths. Prevention of short admis-
sions close to death will facilitate dying at the place of
wish. Patients' clinical conditions and preferences as well
as several healthcare characteristics such as the patients'
treatment focus or the involvement of their primary care
physicians, are associated with hospital transfers. The
extent to which these factors might improve quality of
end-of-life care by preventing unnecessary hospital admis-
sions and facilitating dying at the place of wish, needs to
be studied in future research.
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